LeonaBio (LONA) Net Cash Flow (QoQ) (2020 - 2026)
LeonaBio (LONA) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -175.29% |
| Dec 31, 2025 | 4,808.92% |
| Sep 30, 2025 | 115.04% |
| Jun 30, 2025 | 70.21% |
| Mar 31, 2025 | 23.53% |
| Dec 31, 2024 | -479.06% |
| Sep 30, 2024 | -217.49% |
| Jun 30, 2024 | 133.16% |
| Mar 31, 2024 | 35.38% |
| Dec 31, 2023 | -499.57% |
| Sep 30, 2023 | -139.00% |
| Jun 30, 2023 | -10.41% |
| Mar 31, 2023 | 3.29% |
| Dec 31, 2022 | 213.97% |
| Sep 30, 2022 | 64.81% |
| Jun 30, 2022 | -404.04% |
| Mar 31, 2022 | 133.22% |
| Dec 31, 2021 | 113.17% |
| Sep 30, 2021 | -728.49% |
| Jun 30, 2021 | -94.23% |